FT Health Discusses R&D In Health, Features Interview With Head Of European Network Of Rare Disease Organizations

FT Health: Boost for neglected disease funding
The latest issue of the Financial Times’ weekly global health newsletter discusses data from the G-Finder report on funding for neglected diseases research and development (R&D) and highlights an FT report on the future of R&D in health. The newsletter also features an interview with Yann Le Cam, head of Eurordis, the European network of rare disease organizations, who discusses a new report on improving access to medicines, as well as provides a round-up of global health-related news stories (Dodd/Jack, 1/25).